terminology and guidelines for glaucoma ii - Kwaliteitskoepel
terminology and guidelines for glaucoma ii - Kwaliteitskoepel
terminology and guidelines for glaucoma ii - Kwaliteitskoepel
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
COMBINATION THERAPY<br />
Starting* Additional* Remarks<br />
α2-agonists<br />
β-blockers<br />
topical CAI<br />
prostagl<strong>and</strong>is<br />
prostamides<br />
sympathomimetics<br />
Good additive IOP - lowering effect<br />
Additional IOP lowering effect is relatively poor<br />
β-blockers α 2 -agonist Good additive IOP - lowering effect<br />
topical CAIs<br />
Good additive IOP - lowering effect<br />
Available in combined preparation<br />
prostagl<strong>and</strong>ins Good additive IOP - lowering effect<br />
Available in combined preparation<br />
prostamides<br />
Good additive IOP - lowering effect<br />
sympathomimetics<br />
Topical CAIs<br />
Cholinergic<br />
Prostagl<strong>and</strong>in<br />
Prostamides<br />
α 2 -agonists<br />
β-blockers<br />
prostagl<strong>and</strong>ins<br />
prostamides<br />
sympathomimetics<br />
α 2 -agonists<br />
β-blockers<br />
topical CAIs<br />
α 2 -agonists<br />
β-blockers<br />
topical CAI<br />
sympathomimetics<br />
α 2 -agonists<br />
β-blockers<br />
topical CAI<br />
sympathomimetics<br />
Available in combined preparation<br />
Additional IOP lowering effect is relatively poor<br />
Available in combined preparation<br />
Available in combined preparation<br />
* these columns are listed in alphabetic order<br />
Ch. 3 - 22 EGS